市場調查報告書
商品編碼
1511298
超音波探頭的全球市場,預測到 2030 年:按產品類型、按類型、按年齡層、按銷售管道、按應用、按最終用戶、按地區Ultrasound Probes Market Forecasts to 2030 - Global Analysis By Product Type, Type, Age Group, Sales Channel, Application, End User and by Geography |
根據Stratistics MRC的數據,2024年全球超音波探頭市場規模為39.1億美元,預計到2030年將達到54.5億美元,預測期內複合年成長率為5.70%。
換能器(超音波探頭)是超音波成像系統的重要組成部分。透過將電能轉換為聲波,反之亦然,這些設備使我們能夠看到身體結構的內部。高頻聲波從探頭出並在體內的器官和組織上反射。然後探頭拾取這些回波,將其轉換為電訊號,並對其進行處理以產生詳細的圖像。超音波探頭有多種尺寸和形狀,每種探頭均針對特定應用而設計,例如血管、心臟或腹部。
根據美國心臟協會的說法,保持健康飲食和定期運動對於預防心血管疾病非常重要。
對微創技術的需求不斷增加
全球趨勢正在轉向微創手術,因為與傳統手術方法相比,微創手術恢復時間更短、併發症更少、患者預後更好。此外,在超音波導引手術中使用專用探頭可以精確定位治療部位,例如針活體組織切片和導管放置,從而提高手術的安全性和有效性。
最先進的設備價格過高
超音波系統和探頭會在醫療機構中產生大量初始資本成本和持續維護成本,特別是在資源有限的地區。這種財務障礙阻礙了採用率,特別是在預算有限的小型診所和醫療保健機構。此外,培訓員工操作和解釋超音波影像的成本很高,進一步增加了整體成本。
照護現場( POCUS) 的開發
在各種臨床環境中,包括急診醫學、重症加護和基層醫療,照護現場( POCUS) 因其便攜性、即時影像處理功能和經濟實惠而變得越來越受歡迎。此外,可攜式手持式超音波診斷設備的結合改善了臨床決策,降低了與傳統成像方式相關的醫療成本,並能夠在患者床邊進行快速診斷評估。
價格敏感度和競爭壓力
定價壓力來自多個市場參與者的存在以及超音波探頭製造商之間的激烈競爭,特別是在成本敏感的醫療保健環境中。價格競爭也會影響市場佔有率和利潤率,特別是對於銷售沒有獨特功能或最尖端科技的商品化超音波探頭的業者而言。
COVID-19 大流行對超音波探頭市場產生了重大影響。最初,門診就診和非緊急醫療程序顯著減少,從而減少了對超音波探頭和其他診斷影像技術的需求。醫院必須優先考慮 COVID-19 治療,而不是其他業務問題,包括人員短缺、重新分配資源以及延遲設備升級和採購。此外,由於大流行,遠端醫療和照護現場超音波(POCUS) 趨勢的加速推動了對用於遠距離診斷的可攜式手持超音波設備的需求。
預計探針細分市場在預測期內將是最大的
在超音波探頭市場中,探頭細分市場佔有最大佔有率。本文介紹了用於醫學影像和診斷的各種類型的超音波探頭。超音波探頭是超音波檢查系統的重要組成部分,允許醫療專業人員在不做切口的情況下查看內部器官和組織。此外,技術的進步導致了成像能力提高、解析度提高和便攜性增強的探頭的開發,這些探頭現在被用於各種醫療環境,包括診所、醫院,甚至偏遠地區。
無線超音波探頭產業預計在預測期內複合年成長率最高
在超音波探頭市場中,無線超音波探頭領域的複合年成長率最高。這一成長背後有許多因素推動了全球醫療保健環境的需求。無線超音波探頭比有線超音波探頭更加靈活和可操作,使醫療保健工作者的掃描更加方便和高效。此外,無線技術的進步也提高了無線超音波探頭的品質和可靠性,進一步提高了其普及度。
北美在超音波探頭市場中佔據最大佔有率。這一優勢背後的主要因素是先進的醫療基礎設施、技術創新的快速採用以及對醫療保健研發的大量投資。現代醫療設備和診斷工具,例如超音波探頭,在北美,尤其是美國的需求量很大。此外,有利的報銷政策以及積極的早期診斷和預防性醫療保健方法推動了該地區在超音波探頭市場的領先地位。
在超音波探頭市場中,亞太地區的複合年成長率最高。許多因素促成了這種快速成長,包括醫療成本上升、醫療基礎設施改善以及公眾對早期診斷和疾病預防意識的提高。這一成長的主要參與者包括中國、印度、日本和韓國。此外,手持式和可攜式超音波診斷設備的普及等技術開拓正在加速亞太地區的市場擴張。
According to Stratistics MRC, the Global Ultrasound Probes Market is accounted for $3.91 billion in 2024 and is expected to reach $5.45 billion by 2030 growing at a CAGR of 5.70% during the forecast period. Transducers, or ultrasound probes, are crucial parts of ultrasound imaging systems. By converting electrical energy into sound waves and vice versa, these gadgets make it possible to see inside bodily structures. High-frequency sound waves are emitted by the probe and bounce off organs and tissues inside the body. Moreover, the probe picks up these echoes and transforms them back into electrical signals, which are then processed to produce finely detailed pictures. Ultrasound probes are available in a range of sizes and forms, each designed for a particular use, such as vascular, cardiac, or abdominal imaging.
According to the American Heart Association, maintaining a healthy diet and regular physical activity are crucial in preventing cardiovascular diseases.
Increasing requirement for less invasive techniques
Globally, there is a trend toward less invasive procedures because they are associated with shorter recovery periods, fewer complications, and better patient outcomes than conventional surgical methods. Additionally, the use of specialized probes in ultrasound-guided procedures allows for precise targeting of treatment areas, such as needle biopsies or catheter placements, thereby improving procedural safety and efficacy.
Exorbitant price of cutting-edge equipment
High-end ultrasound systems and probes can come with significant upfront capital costs and ongoing maintenance costs for medical facilities, particularly in areas with limited resources. Adoption rates are hampered by this financial barrier, especially in smaller clinics and healthcare facilities with tighter budgets. Furthermore, the overall cost is further increased by the expense of training staff members to operate and interpret ultrasound images.
Development of point-of-care ultrasonography (POCUS)
In a variety of clinical contexts, such as emergency medicine, critical care, and primary care, point-of-care ultrasound (POCUS) is becoming more and more popular because of its portability, real-time imaging capabilities, and affordability. Moreover, incorporating portable and handheld ultrasound devices improves clinical decision-making, lowers healthcare costs related to traditional imaging modalities, and allows for rapid diagnostic assessments at the patient's bedside.
Price sensitivity and competitive pressure
Price pressure arises from the presence of multiple market players and intense competition among ultrasound probe manufacturers, especially in healthcare environments where costs are critical. Additionally, price competition can have an impact on market share and profit margins, particularly for businesses selling commoditized ultrasound probes that lack unique features or cutting-edge technology.
The COVID-19 pandemic had a major effect on the market for ultrasound probes. There was initially a significant drop in outpatient visits and non-urgent medical procedures, which decreased the need for ultrasound probes and other diagnostic imaging technologies. Hospitals had to prioritize COVID-19 treatment over other operational issues, such as staffing shortages, resource reallocation, and equipment upgrades and purchases being delayed. Furthermore, the need for portable and handheld ultrasound devices for remote diagnostics was fueled by the pandemic's acceleration of telemedicine and point-of-care ultrasound (POCUS) trends.
The Probe segment is expected to be the largest during the forecast period
The probe segment has the largest share in the ultrasound probe market. This section covers the different kinds of ultrasound probes that are used in imaging and diagnostics in medicine. Ultrasound probes are vital parts of ultrasonography systems that allow medical professionals to view internal organs and tissues without making any incisions. Moreover, the development of probes with improved imaging capabilities, greater resolutions, and greater portability has been made possible by technological advancements, and these probes can now be used in a variety of medical settings, including clinics, hospitals, and even remote areas.
The Wireless Ultrasound Probe segment is expected to have the highest CAGR during the forecast period
Within the ultrasound probe market, the wireless ultrasound probe segment exhibits the highest CAGR. Numerous factors driving demand in healthcare settings globally can be attributed to this growth. Compared to their wired counterparts, wireless ultrasound probes are more flexible and mobile, which makes scanning more convenient and efficient for medical professionals. Additionally, the quality and dependability of wireless ultrasound probes have also improved due to advancements in wireless technology, which has fueled their adoption even more.
North America holds the largest market share for ultrasound probes. The primary factors contributing to this dominance are the sophisticated healthcare infrastructure, the rapid adoption of technological innovations, and the significant investments made in healthcare R&D. Modern medical equipment and diagnostic tools, such as ultrasound probes, are in high demand in North America, especially in the United States. Furthermore, the region leads the ultrasound probe market in part because of advantageous reimbursement policies and a proactive approach to early diagnosis and preventive healthcare.
In the ultrasound probe market, the Asia-Pacific region has the highest CAGR. Numerous factors, such as rising healthcare costs, growing healthcare infrastructure, and growing public awareness of early diagnosis and disease prevention, are contributing to this rapid growth. Key players in this growth include China, India, Japan, and South Korea. Furthermore, technological developments like the widespread use of handheld and portable ultrasound equipment are hastening market expansion in the Asia-Pacific area.
Key players in the market
Some of the key players in Ultrasound Probes market include GE Healthcare, Hitachi Medical Systems, Fujifilm Holdings Corporation, RamSoft, Inc., Samsung Electronics Co., Ltd., Esaote SpA, Analogic Corporation, Healcerion Co., Ltd., Canon Medical Systems, Siemens Healthcare GmbH , Terason Corporation, Philips Healthcare, Trivitron Healthcare, Akumin Inc., Koninklijke Philips N.V. , Hologic Inc. , Toshiba Corporation and Sonic Healthcare Limited.
In April 2024, FUJIFILM Wako Chemicals U.S.A. Corporation (Fujifilm), a supplier of high purity chemicals and reagents, and Predictive Oncology Inc., , a leader in AI-driven drug discovery and biologics, announced that the companies have entered into a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products.
In December 2023, GE Healthcare has entered into a distribution agreement with mobile-first clinical surveillance technology provider, AirStrip to expand AirStrip Cardiology and Patient Monitoring solutions in the US.The mobile application from AirStrip enables clinicians to view clinical data on the web and on mobile devices.
In April 2023, Philips Healthcare has secured a contract to provide its HealthSuite Imaging PACS to Amazon Web Services (AWS).The deal builds on an existing arrangement between Philips and AWS that includes Amazon Bedrock for cloud-based artificial intelligence (AI) applications that support clinical decision-making, Philips said.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.